Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock
ARCK
ARCK was delisted on the 12th of January, 2023.
24 hedge funds and large institutions have $59.1M invested in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$14.9M |
| 2 |
SCM
Saba Capital Management
New York
|
+$11.2M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$4.48M |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$3.85M |
| 5 |
FTCM
Fir Tree Capital Management
New York
|
+$3.47M |
Top Sellers
ARCK Hedge Fund Activity: Q4 2021 in Review
24 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) for Q4 2021, worth a combined $59.1M.
Buyers outnumbered sellers: 24 funds opened new ARCK positions and 0 closed out — a net gain of 24 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Beryl Capital Management, opening a new position worth an estimated $14.9M.
- 24 institutional investors held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $59.1M of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock stock for Q4 2021.
- 24 funds opened new Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock positions in Q4 2021 and 0 closed out, a net change of +24 holders.
- The largest Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock buyer in Q4 2021 was Beryl Capital Management, an estimated $14.9M added.
Based on aggregated 13F filings for Q4 2021.